Biochemical and functional assessment of equine lymphocyte phosphodiesterases and protein kinase C

Veterinary Immunology and Immunopathology

Volumn 98, Issue 3-4, 2004, Pages 153-165

  Rickards, K J ^a,b   Page, C P ^b   Hamblin, A S ^a   Goode, N T ^a   Cunningham, F M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Allergic inflammation; Lymphocytes; Phosphodiesterase; Protein kinase C

Indexed keywords

ADENOSINE 2',3' PHOSPHATE; CYCLIC GMP; ISOENZYME; PHOSPHODIESTERASE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; PROTEIN KINASE C THETA; PROTEIN KINASE C ZETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION; PROTEINASE INHIBITION;

ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL DIVISION; CYCLIC AMP; CYCLIC GMP; HORSES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LYMPHOCYTES; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PROTEIN KINASE C;

EQUIDAE;

EID: 1542358761     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2003.12.001     Document Type: Article

References (57)

1. Adolfsson P.I., Ahlstrand C., Varenhorst E., Svensson S.P. Lysophosphatidic acid stimulates proliferation of cultured smooth muscle cells from human BPH tissue: sildenafil and papaverin generate inhibition. Prostate. 51:2002;50-58.
2. Altman A., Isakov N., Baier G. Protein kinase Ctheta: a new essential superstar on the T-cell stage. Immunol. Today. 21:2000;567-573.
3. Baier G., Telford D., Giampa L., Coggeshall K.M., Baier-Bitterlich G., Isakov N., Altman A. Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J. Biol. Chem. 268:1993;4997-5004.
4. Ballard S.A., Gingell C.J., Tang K., Turner L.A., Price M.E., Naylor A.M. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J. Urol. 159:1998;2164-2171.
5. Banner K.H., Bertin B., Moodley I., Page C.P. Effect of isoenzyme selective phosphodiesterase inhibitors on the proliferation of murine thymus and spleen cells. Pulm. Pharmacol. 9:1996;35-41.
6. Banner K.H., Roberts N.M., Page C.P. Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis. Br. J. Pharmacol. 116:1995;3169-3174.
7. Betz M., Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:1991;108-113.
8. Birchall A.M., Bishop J., Bradshaw D., Cline A., Coffey J., Elliott L.H., Gibson V.M., Greenham A., Hallam T.J., Harris W.et al. Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J. Pharmacol. Exp. Ther. 268:1994;922-929.
9. Briggs W.A., Wu Q., Orgul O., Choi M., Scheel P.J. Jr., Burdick J. Lymphocyte suppression by rolipram with other immunosuppressive drugs. J. Clin. Pharmacol. 39:1999;794-799.
10. Chan S.C., Li S.H., Hanifin J.M. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J. Invest. Dermatol. 100:1993;681-684.
11. Cooper K.D., Kang K., Chan S.C., Hanifin J.M. Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro. J. Invest. Dermatol. 84:1985;477-482.
12. Dekker L.V., McIntyre P., Parker P.J. Mutagenesis of the regulatory domain of rat protein kinase C-eta. A molecular basis for restricted histone kinase activity. J. Biol. Chem. 268:1993;19498-19504.
13. Drummer H.E., Reubel G.H., Studdert M.J. Equine gammaherpesvirus 2 (EHV2) is latent in B lymphocytes. Arch. Virol. 141:1996;495-504.
14. England K., Rumsby M.G. Changes in protein kinase C epsilon phosphorylation status and intracellular localization as 3T3 and 3T6 fibroblasts grow to confluency and quiescence: a role for phosphorylation at ser-729? Biochem. J. 352:2000;19-26.
15. Epstein, P., Hachisu, R., 1984. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphoblasts. In: Strada, S., Thompson, W. (Eds.), Advances of Cyclic Nucleotide and Protein Phosphorylation Research. Raven, New York, pp. 304-321.
16. Essayan D.M., Huang S.K., Kagey-Sobotka A., Lichtenstein L.M. Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression. J. Allergy Clin. Immunol. 99:1997;28-37.
17. Fawcett L., Baxendale R., Stacey P., McGrouther C., Harrow I., Soderling S., Hetman J., Beavo J.A., Phillips S.C. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3702-3707.
18. Fischer T.A., Palmetshofer A., Gambaryan S., Butt E., Jassoy C., Walter U., Sopper S., Lohmann S.M. Activation of cGMP-dependent protein kinase Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells. J. Biol. Chem. 276:2001;5967-5974.
19. Fraser J.D., Straus D., Weiss A. Signal transduction events leading to T-cell lymphokine gene expression. Immunol. Today. 14:1993;357-362.
20. Fulop T. Jr., Leblanc C., Lacombe G., Dupuis G. Cellular distribution of protein kinase C isozymes in CD3-mediated stimulation of human T lymphocytes with aging. FEBS Lett. 375:1995;69-74.
21. Gantner F., Gotz C., Gekeler V., Schudt C., Wendel A., Hatzelmann A. Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation. Br. J. Pharmacol. 123:1998;1031-1038.
22. Gantner F., Tenor H., Gekeler V., Schudt C., Wendel A., Hatzelmann A. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. J. Allergy Clin. Immunol. 100:1997;527-535.
23. Giembycz M.A., Corrigan C.J., Seybold J., Newton R., Barnes P.J. Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br. J. Pharmacol. 118:1996;1945-1958.
24. Gonzalez-Amaro R., Portales-Perez D., Baranda L., Redondo J.M., Martinez-Martinez S., Yanez-Mo M., Garcia-Vicuna R., Cabanas C., Sanchez-Madrid F. Pentoxifylline inhibits adhesion and activation of human T lymphocytes. J. Immunol. 161:1998;65-72.
25. Greenaway E.C., Cunningham F.M., Goode N.T. Differential localization of protein kinase C isotypes in equine eosinophils and neutrophils. J. Leukocyte Biol. 68:2000;575-582.
26. Han Z., Pantazis P., Lange T.S., Wyche J.H., Hendrickson E.A. The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C. Cell. Death Differ. 7:2000;521-530.
27. Hassan J., Rainsford E., Reen D.J. Linkage of protein kinase C-beta activation and intracellular interleukin-2 accumulation in human naive CD4 T cells. Immunology. 92:1997;465-471.
28. Hidi R., Timmermans S., Liu E., Schudt C., Dent G., Holgate S.T., Djukanovic R. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis. Eur. Resp. J. 15:2000;342-349.
29. Kirman J., Le Gros G. Which is the true regulator of TH2 cell development in allergic immune responses? Clin. Exp. Allergy. 28:1998;908-910.
30. Kishimoto A., Kajikawa N., Shiota M., Nishizuka Y. Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J. Biol. Chem. 258:1983;1156-1164.
31. Kontny E., Kurowska M., Szczepanska K., Maslinski W. Rottlerin, a PKC isozyme-selective inhibitor, affects signaling events and cytokine production in human monocytes. J. Leukocyte Biol. 67:2000;249-258.
32. Kydd J., Antczak D., Allen W., Barbis D., Butcher G., Davis W., Duffus W., Edgington N., Grunig G., Holmes M., Lunn D., McCulloch J., O'Brien A., Perryman L., Tavernor A., Williamson S., Zhang C. Report of the first international workshop on leucocyte antigens, Cambridge, UK, July 1991. Vet. Immunol. Immunopathol. 42:1994;3-60.
33. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
34. Landells L.J., Spina D., Souness J.E., O'Connor B.J., Page C.P. A biochemical and functional assessment of monocyte phosphodiesterase activity in healthy and asthmatic subjects. Pulm. Pharmacol. Ther. 13:2000;231-239.
35. Landells L.J., Szilagy C.M., Jones N.A., Banner K.H., Allen J.M., Doherty A., O'Connor B.J., Spina D., Page C.P. Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects. Br. J. Pharmacol. 133:2001;722-729.
36. Lavoie J.P., Maghni K., Desnoyers M., Taha R., Martin J.G., Hamid Q.A. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am. J. Resp. Crit. Care Med. 164:2001;1410-1413.
37. Li L., Yee C., Beavo J.A. CD3-and CD28-dependent induction of PDE7 required for T cell activation. Science. 283:1999;848-851.
38. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
39. Manganiello V.C., Murata T., Taira M., Belfrage P., Degerman E. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch. Biochem. Biophys. 322:1995;1-13.
40. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marme D., Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268:1993;9194-9197.
41. McGorum B.C., Dixon P.M., Halliwell R.E. Phenotypic analysis of peripheral blood and bronchoalveolar lavage fluid lymphocytes in control and chronic obstructive pulmonary disease affected horses, before and after natural (hay and straw) challenges. Vet. Immunol. Immunopathol. 36:1993;207-222.
42. McKelvie J., Foster A.P., Cunningham F.M., Hamblin A.S. Characterisation of lymphocyte subpopulations in the skin and circulation of horses with sweet itch (Culicoides hypersensitivity). Equine Vet. J. 31:1999;466-472.
43. McKelvie J., Little S., Foster A.P., Cunningham F.M., Hamblin A. Equine peripheral blood mononuclear cells proliferate in response to tetanus toxoid antigen. Res. Vet. Sci. 65:1998;91-92.
44. Nicholson C.D., Shahid M. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes - their potential utility in the therapy of asthma. Pulm. Pharmacol. 6:1993;101-117.
45. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 334:1988;661-665.
46. Rickards K., Page C., Lees P., Cunningham F. Phosphodiesterase activity in neutrophils from horses with chronic obstructive pulmonary disease. Vet. Immunol. Immunopathol. 76:2000;319-330.
47. Siedek E., Little S., Mayall S., Edington N., Hamblin A. Isolation and characterisation of equine dendritic cells. Vet. Immunol. Immunopathol. 60:1997;15-31.
48. Soderling S.H., Bayuga S.J., Beavo J.A. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8991-8996.
49. Soderling S.H., Bayuga S.J., Beavo J.A. Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J. Biol. Chem. 273:1998;15553-15558.
50. Soderling S.H., Bayuga S.J., Beavo J.A. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7071-7076.
51. Szamel M., Resch K. T-cell antigen receptor-induced signal-transduction pathways - activation and function of protein kinases C in T lymphocytes. Eur. J. Biochem. 228:1995;1-15.
52. Tenor H., Hatzelmann A., Church M.K., Schudt C., Shute J.K. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br. J. Pharmacol. 118:1996;1727-1735.
53. Tenor H., Staniciu L., Schudt C., Hatzelmann A., Wendel A., Djukanovic R., Church M.K., Shute J.K. Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes. Clin. Exp. Allergy. 25:1995;616-624.
54. Watson J.L., Stott J.L., Blanchard M.T., Lavoie J.P., Wilson W.D., Gershwin L.J., Wilson D.W. Phenotypic characterization of lymphocyte subpopulations in horses affected with chronic obstructive pulmonary disease and in normal controls. Vet. Pathol. 34:1997;108-116.
55. Way K.J., Chou E., King G.L. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21:2000;181-187.
56. Wilkinson S.E., Nixon J.S. T-cell signal transduction and the role of protein kinase C. Cell Mol. Life Sci. 54:1998;1122-1144.
57. Winder N.C., von Fellenberg R. Chronic small airway disease in the horse: immunohistochemical evaluation of lungs with mild, moderate and severe lesions. Vet. Rec. 122:1988;181-183.